Immunotherapy and Irreversible Electroporation for Advanced Pancreatic Cancer
Phase 2
10
about 12 years
18+
1 site in KY
About this study
Researchers are testing whether irreversible electroporation, given together with Nivolumab, can help people with locally advanced pancreatic cancer. The trial will also look at how well this treatment works and if it causes any side effects.
Based on ClinicalTrials.gov records.
What participants do
- 1.Take Nivolumab
- 2.Undergo Irreversible Electroporation
Participation effort
Estimated from trial records. Details can vary by site.
Logistics difficulty varies by site location and availability.
Trial highlights
Treatment details
Auto-extracted from trial records to preview treatments and outcomes.
nivolumab (Immune checkpoint inhibitor; blocks PD-1 receptor on T cells)
infusion
Primary: Safety and Tolerability of Combination Irreversible Electroporation and Nivolumab Treatment
Secondary: Overall Survival, Progression Free Survival